Pete A. Meyers
Pete joined Eagle in May 2017 with more than 2 decades of experience in the healthcare industry. From 2016 to 2017, he served as Chief Financial Officer of Motif BioSciences, Inc. Prior to joining Motif, Pete spent 3 years as Chief Financial Officer and Treasurer of TetraLogic Pharmaceuticals Corporation.
Pete has 18 years of experience as a healthcare investment banker, including Co-Head of Global Health Care Investment Banking at Deutsche Bank Securities Inc. Pete currently serves on the board of directors and chairs the Audit Committee of Immutep Ltd.
Pete holds a BS in finance from Boston College and an MBA in finance from Columbia Business School.